Log in
Lost password
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  Impax Laboratories Inc    IPXL   US45256B1017

News SummaryMost relevantAll newsSector news 

Impax Laboratories Inc : Impax Laboratories to Present at the UBS Global Healthcare Conference

05/20/2013 | 07:35am US/Eastern

Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the Company will present at the UBS Global Healthcare Conference on Wednesday, May 22, at 9:00 a.m. Eastern Standard Time. The conference will be held at the Sheraton New York Hotel.

Individuals may listen to the live or an archived presentation made at the conference, which will be posted in the investor relations section of the Company's web site at www.impaxlabs.com. This presentation will be archived on the Company's web site for 30 days.

About Impax Laboratories, Inc.

Impax Laboratories, Inc. (Impax) is a technology based specialty pharmaceutical company applying its formulation expertise and drug delivery technology to the development of controlled-release and specialty generics in addition to the development of central nervous system disorder branded products. Impax markets its generic products through its Global Pharmaceuticals division and markets its branded products through the Impax Pharmaceuticals division. Additionally, where strategically appropriate, Impax develops marketing partnerships to fully leverage its technology platform and pursues partnership opportunities that offer alternative dosage form technologies, such as injectables, nasal sprays, inhalers, patches, creams and ointments. For more information, please visit the Company's Web site at: www.impaxlabs.com.

Impax Laboratories, Inc.
Mark Donohue, 215-558-4526
Investor Relations and Corporate Communications

© Business Wire 2013
React to this article
06/30 IMPAX LABORATORIES : Entry into a Material Definitive Agreement, Termination of ..
06/25 IMPAX LABORATORIES : IPXL) is Trading Lower on Unusual Volume for June 25
06/25 IMPAX LABORATORIES : Other Events, Financial Statements and Exhibits (form 8-K)
06/25 IMPAX LABORATORIES : Prices Private Offering of Convertible Senior Notes
06/24 IMPAX LABORATORIES : Regulation FD Disclosure, Other Events (form 8-K)
06/24 IMPAX LABORATORIES : Announces Private Offering of Convertible Senior Notes
06/24 IMPAX LABORATORIES : FDA Approves ZOMIG® zolmitriptan Nasal Spray for Migraine i..
06/16 IMPAX LABORATORIES : FDA Approves ZOMIG® (zolmitriptan) Nasal Spray for Migraine..
06/15 Impax reportedly buys 32-MW Irish wind project
06/04 IMPAX LABORATORIES : to Present at the Goldman Sachs 36th Annual Global Healthca..
Duration : Period :
Impax Laboratories Inc Technical Analysis Chart | IPXL | US45256B1017 | 4-Traders
Income Statement Evolution
More Financials